St. Elisabeth Gruppe GmbH, St. Anna Hospital Herne

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Organ Preservation With Durvalumab-based Immunotherapy in Combination With Chemoradiation as Definitive Therapy for Early Stage Esophageal Adenocarcinoma With Indication for Radical Surgery	esophageal adenocarcinoma	Active, not recruiting	Phase 2	2026-08-07		NCT05713838

Clinical trials